BPC-157

About BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. It's derived from a partial sequence found in human gastric juice protein BPC. This stable peptide fragment shows impressive protective properties in lab research models. The compound works through several pathways. It boosts VEGF expression to promote new blood vessel formation, influences growth hormone receptor activity, and helps stabilise the connections between cells. Research focuses mainly on speeding up wound healing, protecting the gut lining, and studying how connective tissues repair themselves. Lab studies have produced some interesting findings. There's been improved healing where tendons attach to bone, better collagen production, and protection against stomach ulcers in research models. The peptide remains stable in the body and is readily absorbed when used in research settings. Premio Peptides supplies BPC-157 as a high-purity freeze-dried powder (≥98% HPLC purity). It's manufactured under strict GMP conditions to ensure consistent results across research studies. Each vial contains precisely measured amounts that work well for dose-response experiments and mechanistic research. This research-grade compound is designed exclusively for laboratory use and experimental research protocols.

Research Applications

• Investigated in preclinical tendon and ligament repair models for its role in fibroblast migration and collagen organisation.
• Studied for its association with gastric mucosal integrity and gut barrier signalling in rodent models.
• Researched for its role in angiogenic pathways including VEGFR2 expression and capillary formation in vitro.
• Examined for involvement in nitric oxide synthesis pathways and modulation of inflammatory cytokine cascades.

Research Mechanism — BPC-157

A simplified summary of what BPC-157 is studied for in research models. For laboratory in-vitro use only.

1. 1

   Molecular target

   A pentadecapeptide investigated for its interaction with growth-factor receptors and intracellular signalling complexes in research models.

   • VEGFR2 (vascular endothelial growth factor receptor 2)
   • FAK–paxillin focal-adhesion complex
   • Endothelial nitric-oxide synthase (eNOS)
2. 2

   Investigated pathways

   Preclinical studies have explored downstream effects on the nitric-oxide system, growth-factor signalling, and angiogenesis-related responses in vitro.

   • Nitric-oxide release modulation
   • Endothelial tube-formation assays
   • Fibroblast migration and proliferation
3. 3

   Preclinical research applications

   Used as a research tool in laboratory models exploring tissue-repair biology and gut-mucosa science. Not approved for human use.

   • Tendon and ligament fibroblast research
   • Gastric and intestinal mucosa models
   • Bone-defect healing studies

For research use only. BPC-157 is not approved as a medicine in the UK and is not intended for human or veterinary administration. See the compliance page for full terms.